Active disease without specified complication uses K50.x00 structure
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
The membranes were blocked in QuickBlock Blocking Buffer for 15 min (Beyotime) and then probed with primary antibodies against fibronectin, collagen I, GFAP, -SMA, TGF1, SMAD3, phospho-Smad3 (Thr8), SMAD4, -tubulin, and -actin (Supplementary Table 2)
Research published by Pickart & Margolina in the International Journal of Molecular Sciences (2018) confirmed GHK-Cu upregulates genes involved in collagen synthesis and tissue remodeling
Prepared with an emphasis on quality, consistency, and laboratory handling standards
Key Benefits: - Stimulates collagen and elastin for firmer, tighter skin